CalciMedica, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2019 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
CalciMedica, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2019 to Q4 2024.
  • CalciMedica, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$4.26M, a 2.7% decline year-over-year.
  • CalciMedica, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$13.7M, a 60.1% increase year-over-year.
  • CalciMedica, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$13.7M, a 60.1% increase from 2023.
  • CalciMedica, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$34.4M, a 339% decline from 2022.
  • CalciMedica, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$7.82M, a 78.2% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$13.7M -$4.26M -$112K -2.7% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-27
Q3 2024 -$13.6M -$5.62M -$999K -21.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$12.6M -$3.95M +$2.35M +37.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-13
Q1 2024 -$14.9M $130K +$19.4M Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-13
Q4 2023 -$34.4M -$4.15M -$5.56M -393% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-27
Q3 2023 -$28.8M -$4.62M -$2.04M -79% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$26.8M -$6.3M -$3.27M -108% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-13
Q1 2023 -$23.5M -$19.3M -$15.7M -431% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-13
Q4 2022 -$7.82M $1.42M +$10.1M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$17.9M -$2.58M +$5.41M +67.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$23.3M -$3.03M +$4.68M +60.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-09
Q1 2022 -$28M -$3.63M +$7.82M +68.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-09
Q4 2021 -$35.8M -$8.68M +$477K +5.21% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 -$36.3M -$7.99M -$3.27M -69.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$33M -$7.71M -$1.84M -31.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$31.2M -$11.4M -$3.66M -46.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$27.5M -$9.15M +$1.12M +10.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 -$28.7M -$4.72M +$5.49M +53.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$34.1M -$5.87M +$4.39M +42.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-12
Q1 2020 -$38.5M -$7.79M -$1.5M -23.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-12
Q4 2019 -$37M -$10.3M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-05
Q3 2019 -$10.2M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$10.3M Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-12
Q1 2019 -$6.3M Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.